Reynolds HN, McCunn M, Borg U, Habashi N, Cottingham C, Bar-Lavi Y
Division of Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland Medical System, 22 S Greene Street, Baltimore, MD 21201, USA.
Crit Care. 1998;2(1):29-34. doi: 10.1186/cc121.
Various estimates of the incidence and mortality rate of the acute (adult) respiratory distress syndrome (ARDS) have been published. The studies that led to those estimates were based on relatively small patient populations and employed variable diagnostic identifiers of ARDS. The purpose of this study was to estimate the incidence of ARDS and its mortality rate from a large database to which refined diagnostic criteria were applied. We conducted a retrospective review of all hospital discharges over a 4-year period, using screening criteria designed to select patients with ARDS. Discharges from all acute care hospitals in the state of Maryland were reviewed using a computer database from the Health Services Cost Review Commission (HSCRC). Patients >/= 12 years of age were included. Screening criteria consisted of ICD-9 codes 518.5 and 518.82 cross-referenced with procedural codes for ventilatory support (96.70, 96.71 and 96.72). Data were normalized to the number of cases per 100,000 people. RESULTS: During the 4-year study period there were 2,501,147 hospitalizations. Applying the ICD-9 ARDS criteria yielded lower and upper limits of 159-205, 439-568, 531-694 and 529-720 cases of ARDS for 1992, 1993, 1994 and 1995, respectively. Normalizing for a population of 5 million yields yearly lower and upper limit rates of 3.2-4.2, 8.8-11.4, 10.6-13.8 and 10.5-14.2 cases of ARDS per 100,000 people. Mortality upper and lower limit rates based upon the same duration, admissions and population were 38-49%, 39-52%, 36-47%, and 36-49%, respectively. CONCLUSIONS: The incidence of ARDS in Maryland is in the range of 10-14 cases per 100,000 people. The ARDS mortality rate is 36% to 52%, similar to that calculated in previous studies.
已发表了关于急性(成人)呼吸窘迫综合征(ARDS)发病率和死亡率的各种估计。得出这些估计值的研究基于相对较小的患者群体,并采用了不同的ARDS诊断标识。本研究的目的是从应用了精细诊断标准的大型数据库中估计ARDS的发病率及其死亡率。我们对4年期间所有医院出院病例进行了回顾性审查,使用筛选标准来选择ARDS患者。利用卫生服务成本审查委员会(HSCRC)的计算机数据库对马里兰州所有急症医院的出院病例进行了审查。纳入年龄大于或等于12岁的患者。筛选标准包括国际疾病分类第九版(ICD - 9)编码518.5和518.82,并与通气支持的程序编码(96.70、96.71和96.72)交叉对照。数据按每10万人中的病例数进行标准化。结果:在4年研究期间,共有2,501,147例住院病例。应用ICD - 9的ARDS标准得出,1992年、1993年、1994年和1995年ARDS病例数的下限和上限分别为159 - 205例、439 - 568例、531 - 694例和529 - 720例。以500万人口进行标准化后,每年每10万人中ARDS病例数的下限和上限率分别为3.2 - 4.2例、8.8 - 11.4例、10.6 - 13.8例和10.5 - 14.2例。基于相同时间段、入院人数和人口的死亡率下限和上限率分别为38% - 49%、39% - 52%、36% - 47%和36% - 49%。结论:马里兰州ARDS的发病率为每10万人10 - 14例。ARDS死亡率为36%至52%,与先前研究计算的结果相似。